Introduction {#s1}
============

In eukaryotes, the replicative DNA polymerases (pols), ε and δ, are responsible for replicating the leading and lagging strands, respectively, and anchor to PCNA sliding clamps encircling the DNA to achieve the high degree of processivity required for efficient DNA replication. This association, referred to as a holoenzyme, tethers the pol to DNA, substantially increasing the extent of continuous replication ([@bib15]). However, the stringent replicative pols cannot accommodate distortions to the native DNA sequence such as such as cyclobutane pyrimidine dimers (CPDs), the major DNA lesions resulting from ultraviolet (UV) irradiation. Upon encountering these lesions, DNA synthesis on the afflicted template abruptly stops but the replication fork progresses onward, exposing the damaged template. Fork progression eventually stalls and replication protein A (RPA) coats the exposed ssDNA, protecting it from cellular nucleases ([@bib14]).

Such arrests may be overcome by translesion DNA synthesis (TLS) where the replicative pol is exchanged for a TLS pol that binds to the resident PCNA and replicates the damaged DNA ([@bib40]). With a more open pol active site and the lack of proofreading activity, TLS pols are able to support stable, yet potentially erroneous, nucleotide incorporation opposite damaged templates allowing DNA synthesis by the replicative pol to resume ([@bib23]). In humans, TLS involves the conjugation of single ubiquitin moieties (that is monoubiquitination) to PCNA clamps encircling blocked primer/template (P/T) junctions and at least seven TLS pols with varying fidelities. However, remarkably low error rates are observed in vivo after exposure to various DNA-damaging agents, indicating a highly efficient process ([@bib14]; [@bib23]; [@bib48]). Currently, the mechanism by which polymerase exchange occurs during human TLS and the role of monoubiquitinated PCNA in this process are unknown.

Monoubiquitination of PCNA is essential for optimal TLS activity in mammalian cells ([@bib18]). The signal for this post-translational modification (PTM) is the buildup and persistence of RPA-coated ssDNA during S-phase. Such structures recruit the Rad6/Rad18 complex to the exposed DNA template where it catalyzes monoubiquitination of lysine residue(s) K164 of the PCNA ring encircling the blocked P/T junction upstream. Hence, this PTM is a generic response that may be elicited by any agent that uncouples DNA synthesis by the replicative pols from replication fork progression, even those that do not modify the DNA at all ([@bib14]). Most studies on the role of monoubiquitinated PCNA during TLS have focused on members of the Y-family of TLS pols, pol η in particular. In human cells, pol η is responsible for the error-free replication of CPDs ([@bib47]). The magnitude of this feat is underscored by xeroderma pigmentosum variant (XPV), a human autosomal recessive genetic disorder in which the *xpv* gene encoding polη is either mutated or deleted, leading to extreme UV sensitivity and skin cancer predisposition ([@bib28]). Following UV irradiation, PCNA encircling damaged DNA is monoubiquitinated during S-phase and pol η co-localizes with PCNA in replication factories (foci) on damaged DNA. Both activities are imperative for TLS following UV irradiation. All Y-family pols contain one or more PCNA-binding domains and at least one ubiquitin-binding domain (UBD) ([@bib40]). The seminal in vivo studies suggested the widely-accepted 'recruitment/displacement' model that the ubiquitin moieties attached to PCNA serve to directly recruit pol η (via its UBD) to sites of DNA damage where it may also displace a blocked replicative pol ([@bib4]; [@bib19]). However, one cannot extrapolate these findings to conclude unequivocally that a direct interaction between pol η and a ubiquitin conjugated to PCNA is required or even occurs during human TLS ([@bib39]). In fact, the collective in vivo evidence suggests otherwise. Firstly, pol η co-localizes with PCNA in replication foci during unperturbed S-phase in human cells and this activity requires the UBD of pol η even though PCNA monoubiquitination is absent ([@bib4]). Secondly, pol η accumulates into replication foci after UV irradiation independently of PCNA monoubiquitination ([@bib13]; [@bib38]) and does not require the UBD of pol η ([@bib7]). Rather, monoubiquitinated PCNA and the UBD of pol η independently retain pol η within replication foci, increasing the residence time of localized pol η. Other reports arrived at the same conclusion but challenged the requirement of the UBD of pol η for TLS following UV irradiation ([@bib1], [@bib2]). Thirdly, in vivo studies on various eukaryotes irradiated with UV suggest that the requirement for PCNA monoubiquitination depends on the location of TLS relative to the replication fork; TLS at/near a stalled replication fork is independent of PCNA monoubiquitination ([@bib11]; [@bib43]) while TLS behind a re-started and progressing replication fork requires PCNA monoubiquitination ([@bib6]; [@bib20]). How then does polymerase switching and TLS occur and what is the role of PCNA monoubiquitination in this process?

We reasoned that TLS pols must bind tighter to monoubiquitinated PCNA than to native PCNA in order for the recruitment/displacement model to be operative. In this report, we performed extensive quantitative studies on human pols δ and η to delineate TLS on the lagging strand. The results clearly demonstrate that the binding of pol η to PCNA and DNA synthesis by a pol η holoenzyme are both independent of PCNA monoubiquitination, refuting the recruitment/displacement model for human TLS. Furthermore, these studies reveal that the unique properties of pols η and δ are attuned to promote a passive and efficient exchange of pols that is independent of PCNA monoubiquitination. Altogether, these studies reveal a novel mechanism for human TLS and direct future studies on the role of PCNA monoubiquitination.

Results {#s2}
=======

Pol η binds to PCNA and monoubiquitinated PCNA with equivalent affinities {#s2-1}
-------------------------------------------------------------------------

Human pol η (referred to herein as pol η) is a single subunit comprised of an N-terminal (residues 1--475) \'catalytic core\' and a C-terminal portion (residues 476--713) containing all protein-protein interaction motifs; a UBD and three PCNA-binding domains that each resemble those from pol δ ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). We utilized FRET to characterize the interaction between pol η and PCNA. FRET between Cy3-pol η and Cy5-PCNA is only observed in the presence of both proteins ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}) and this signal was utilized to determine the affinity of the pol η•PCNA interaction ([Figure 1A](#fig1){ref-type="fig"}, left panel). As observed in [Figure 1B](#fig1){ref-type="fig"}, Cy3-pol η binds to Cy5-PCNA with a *K*~D~ = 120 ± 9.06 nM ([Table 1](#tbl1){ref-type="table"}). To directly compare the binding affinities of pol η for PCNA and monoubiquitinated PCNA, we carried out a FRET-based competition experiment ([Figure 1A](#fig1){ref-type="fig"}, right panel) by titrating a pre-assembled Cy3-Pol η•Cy5-PCNA complex with an unlabeled PCNA competitor. As observed in [Figure 1C](#fig1){ref-type="fig"}, the fraction of Cy3-Pol η•Cy5-PCNA complex decreased with PCNA concentration, indicating that PCNA competes with Cy5-PCNA for binding to Cy3-Pol η (IC~50~ = 308 ± 19.8 nM). A *K*~i~ of 111 ± 7.78 nM is calculated from the IC~50~ for PCNA. As a control, this assay was repeated with pol η ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}), yielding a *K*~i~ of 112 ± 15.5 nM. These *K*~i~ values are identical and both in excellent agreement with the *K*~D~ for the Cy5-PCNA•Cy3-Pol η interaction ([Table 1](#tbl1){ref-type="table"}). Together, this validates the experimental approach. Monoubiquitinated PCNA (referred to herein as (Ub)~3~-PCNA) contains a single ubiquitin moiety on K164 of each monomer within a homotrimeric clamp ring ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). When (Ub)~3~-PCNA was utilized as the unlabeled competitor, a *K*~i~ of 119 ± 10.5 nM was obtained, in excellent agreement with the *K~i~* measured for PCNA ([Table 1](#tbl1){ref-type="table"}). Thus, pol η binds to PCNA and (Ub)~3~-PCNA with equivalent affinities.10.7554/eLife.19788.002Figure 1.Characterizing the interaction between pol η and PCNA.Human pol η contains a UBD and three PCNA-binding domains that each resemble those from pol δ ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). We utilized FRET ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}) to characterize the interaction between full-length, human pol η and PCNA. (**A**) Schematic representation of the equilibrium binding assay (left panel) to measure the binding affinity of Cy3-pol η for Cy5-PCNA ([Figure 1B](#fig1){ref-type="fig"}) and the competitive inhibition assay (right panel) to measure the binding affinity of an unlabeled PCNA for Cy3-pol η ([Figure 1C](#fig1){ref-type="fig"}). (**B**) Cy3-pol η was kept constant, titrated with Cy5-PCNA, and the fraction of bound Cy3-Pol η was measured. Data was plotted as a function of free Cy5-PCNA concentration and each point represents the average ± SD of 3 independent experiments. Fitting to a one-site binding model, yields a *K*~D~ of 120 ± 9.06 nM. (**C**) The Cy3-Pol η•Cy5-PCNA complex was pre-assembled, titrated with an unlabeled PCNA, and the fraction of the Cy3-Pol η•Cy5-PCNA complex remaining was measured. Data was plotted versus the log concentration (in nM) of the respective unlabeled PCNA and each point represents the average ± SD of at least 3 independent experiments. IC~50~ values for PCNA (green) and (Ub)~3~-PCNA (blue) were obtained by fitting to a dose-response inhibition model. As a control, this assay was repeated with pol η ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). *K*~i~ values were calculated from the IC~50~ for each competitor and reported in [Table 1](#tbl1){ref-type="table"}. (Ub)~3~-PCNA contains a single ubiquitin moiety on K164 of each monomer within a homotrimeric clamp ring ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}).**DOI:** [http://dx.doi.org/10.7554/eLife.19788.002](10.7554/eLife.19788.002)10.7554/eLife.19788.003Figure 1---figure supplement 1.PCNA-binding domains of human pol δ and η.Sequence alignment of PCNA-interacting peptide (PIP) boxes from human pols δ ([@bib5]) and η ([@bib26]). The generic amino acid sequence of a canonical PCNA-interacting peptide (PIP) box is shown at the top where 'X' represents any amino acid, '*h'* is a hydrophobic residue (usually L, I, or M), and '*a'* is an aromatic residue (usually F or Y). The canonical PIP-box elements are shown in bold. Non-canonical PIP boxes contain deviations from the conserved residue (shown in bold red).**DOI:** [http://dx.doi.org/10.7554/eLife.19788.003](10.7554/eLife.19788.003)10.7554/eLife.19788.004Figure 1---figure supplement 2.Monitoring the interaction between Pol η and PCNA through FRET.(**A**) Schematic representation of the experiment to monitor FRET under equilibrium conditions. Pol η was N-terminally labeled with Cy3 (Cy3-Pol η). Compared to the unlabeled protein, Cy3-Pol η bound to PCNA with similar affinity ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}) and retained more than 80% of the DNA synthesis activity (see Materials and methods), demonstrating that Cy3 does not compromise pol η activities. Human PCNA was site-specifically labeled with Cy5 (Cy5-PCNA) at amino acid residue 107, as previously described ([@bib16]). This amino acid residue is located on the 'back' face of the PCNA homotrimer, opposite that which interacts with pol η. Interaction between the Cy3-pol η and the Cy5-PCNA was assessed by exciting the Cy3-Pol η with a 514 nm light source and monitoring the fluorescence emission intensities at 570 nm (Cy3 donor fluorescence emission max, I~570~) and 670 nm (Cy5 acceptor fluorescence emission max, I~670~). Cy5-PCNA can be excited through FRET from Cy3-Pol η only when the two dyes are in close proximity (\<∼10 nm). This is indicated by an increase in I~670~ (**B**) Fluorescence emission spectra (540--750 nm) recorded after exciting with a 514 nm light source. The intensities at 670 nm (I~670~) and 570 nm (I~570~) are indicated. In the presence of both proteins (200 nM Cy3-pol η, 20 nM Cy5-PCNA), a dramatic enhancement of I~670~ was observed compared to Cy5-PCNA alone (20 nM). Furthermore, a concomitant decrease in I~570~ was observed compared to Cy3-pol η alone (200 nM). Such behavior is diagnostic of a FRET signal and indicates a protein-protein interaction between Cy3-pol η and Cy5-PCNA.**DOI:** [http://dx.doi.org/10.7554/eLife.19788.004](10.7554/eLife.19788.004)10.7554/eLife.19788.005Figure 1---figure supplement 3.Cy3 does not compromise the affinity of pol η for PCNA.The competitive inhibition assay ([Figure 1C](#fig1){ref-type="fig"}) was repeated with pol η as the unlabeled competitor. The data was plotted versus the log concentration of the unlabeled pol η. Each point represents the average ± SD of 2 independent experiments. The data was fit to a dose-response inhibition model to obtain an IC~50~ value that was utilized to calculate *K*~i~ for pol η. Such analysis yielded a *K*~i~ of 112 ± 15.5 nM for pol η, in excellent agreement with the *K*~D~ for Cy3-pol η (120.1 ± 9.06 nM). This demonstrates that Cy3 does not compromise the ability of pol η to bind PCNA and confirms the validity of the experimental approach.**DOI:** [http://dx.doi.org/10.7554/eLife.19788.005](10.7554/eLife.19788.005)10.7554/eLife.19788.006Figure 1---figure supplement 4.Monoubiquitinated PCNA contains a single ubiquitin moiety on K164 of each monomer within a homotrimeric clamp ring.(Ub)~3~-PCNA (10 pmol monomer, Lane 3) was analyzed by coomassie-blue staining after denaturing 12% SDS-PAGE. Lane 1 contains a molecular weight (MW) marker (sizes in kD are indicated on left) and Lane 2 contains wild-type PCNA (10 pmol monomer). The molecular weight of PCNA (Lane 2) is increased approximately 8.5 kDa by the attachment of a single ubiquitin moiety.**DOI:** [http://dx.doi.org/10.7554/eLife.19788.006](10.7554/eLife.19788.006)10.7554/eLife.19788.007Table 1.Binding affinities (*K*~D~ or *K*~i~) calculated from equilibrium assays carried out in the present study.**DOI:** [http://dx.doi.org/10.7554/eLife.19788.007](10.7554/eLife.19788.007)Binding assaysSubstrateLigand*K*~D~, nMFigure^\*^Cy3-Pol ηCy5-PCNA120 ± 9.061BFLUOR-P/T DNAPol η29.7 ± 4.262Pol δ\~5372FS2Forked Cy3-P/T DNA•Cy5-PCNAPol η28.0 ± 5.383FS1Pol δ\< 10.03FS1Competitive inhibition assaysComplexCompetitor*K*~i~, nMFigure^\*^Cy3-Pol η•Cy5-PCNAPCNA111 ± 7.781C(Ub)~3~-PCNA119 ± 10.51CPol η112 ± 15.51FS3P/T DNA•PCNA•Pol δ\'Dead\' pol η31.7 ± 5.123P/T DNA•(Ub)~3~-PCNA•Pol δ\'Dead\' pol η33.5 ± 5.043[^2]

The DNA binding affinity of pol η drives polymerase exchange {#s2-2}
------------------------------------------------------------

Next, the interaction between pol η and P/T DNA was characterized by fluorescence anisotropy. The fractional saturation of fluorescein-labeled P/T DNA (FLUOR-P/T DNA, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) increased with pol η concentration ([Figure 2](#fig2){ref-type="fig"}) and displayed hyperbolic behavior with a K~D~ = 29.7 ± 4.26 nM. This value is similar to the K~D~ reported for the catalytic core of human pol η (38 ± 4 nM), suggesting that the C-terminus does not contribute significantly to the DNA binding affinity ([@bib46]). Furthermore, the K~D~ for P/T DNA indicates that pol η binds \~4 fold tighter to P/T DNA than to a PCNA ([Table 1](#tbl1){ref-type="table"}). This behavior contrasts that observed for pol δ, which will not form a stable complex with P/T DNA in the absence of PCNA ([@bib17]). Indeed, when these assays were repeated with pol δ, a significant change in the fractional saturation of the FLUOR-P/T DNA was not observed until a 50-fold excess of pol δ was added ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). From the partial binding curve, a K~D~ of 537 nM is estimated, indicating that pol δ binds much weaker (\~18.1 fold) to P/T DNA than pol η does ([Table 1](#tbl1){ref-type="table"}).10.7554/eLife.19788.008Figure 2.The affinity of Pol η for P/T DNA.Fluorescein-labeled P/T DNA (FLUOR-P/T, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) was titrated with pol η and the fraction of bound DNA was measured by fluorescence anisotropy. Data was plotted versus the concentration free pol η and each point represents the average ± SD of at least 3 independent experiments. Fitting to a one-site binding model yields a K~D~ value of 29.7 ± 4.26 nM ([Table 1](#tbl1){ref-type="table"}). This value is more than 18.1-fold less than the *K*~D~ estimated (\~537 nM) for pol δ on the same DNA substrate ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}).**DOI:** [http://dx.doi.org/10.7554/eLife.19788.008](10.7554/eLife.19788.008)10.7554/eLife.19788.009Figure 2---figure supplement 1.DNA substrates.The forked Cy3-P/T and Cy3-TT P/T DNA substrates contain Cy3 donor labels and were utilized for FRET-based studies. The FLUOR-P/T DNA substrate contains a 3'-terminal fluorescein label and was utilized for anisotropy measurements. The Trap P/T substrate contains a 3'-dideoxy-terminated primer and was utilized as a passive trap to monitor primer extension under single turnover conditions. **C** denotes a dideoxy-terminating cytosine nucleotide and the structure is shown in the bottom panel.**DOI:** [http://dx.doi.org/10.7554/eLife.19788.009](10.7554/eLife.19788.009)10.7554/eLife.19788.010Figure 2---figure supplement 2.Pol δ binds much weaker to P/T DNA compared to pol η.The interaction of pol δ with P/T DNA was monitored by fluorescence anisotropy as depicted in [Figure 2](#fig2){ref-type="fig"} Each point is a single measurement for pol δ (●). For comparison, the data is overlaid on the data from [Figure 2](#fig2){ref-type="fig"} for pol η (shown in grey). Fractional saturation values for pol δ were estimated from the range observed for the pol η binding curve. The fractional saturation of FLUOR-P/T DNA remained unchanged up to 200 nM pol δ and a significant change was not observed until 500 nM pol δ was added, suggesting that the DNA binding affinity of pol δ is dramatically lower (\>10 fold) than that for pol η. In order to maintain physiological ionic strength (200 mM), higher concentrations of pol δ could not be added and, hence, a complete binding curve could not be obtained. Based on the range for the pol η binding curve and the experimental value measured at 500 nM pol δ, a K~D~ of 537 nM is estimated for pol δ, indicating that pol η binds much tighter to P/T DNA (\~18.1 fold) than pol δ does.**DOI:** [http://dx.doi.org/10.7554/eLife.19788.010](10.7554/eLife.19788.010)

The aforementioned studies reveal that pol η binds to free PCNA independently of PCNA monoubiquitination but much weaker than to P/T DNA. These findings suggest that pol exchange during TLS may be driven by the P/T DNA binding affinity of pol η. To gauge this possibility, we first analyzed formation of the pol η•PCNA•P/T DNA complex (that is a holoenzyme) ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). Pol η holoenzyme formation increased with pol η concentration ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}) and displayed hyperbolic behavior with a K~D~ (28.0 ± 5.38 nM) identical to that measured for pol η binding to P/T DNA ([Table 1](#tbl1){ref-type="table"}). This suggests that pol η holoenzyme assembly is governed by the affinity of pol η for the P/T DNA, in stark contrast to that observed previously for pol δ under similar conditions ([@bib16]). Pol δ binds to P/T DNA with dramatically low affinity ([Table 1](#tbl1){ref-type="table"}) yet holoenzyme formation increased linearly, plateaued when the concentrations of pol δ and PCNA were equivalent, and flat-lined thereafter ([Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}). Such behavior indicates that the concentration of the P/T DNA•PCNA complex (100 nM) is much greater than ([\>]{.ul}10 fold) the K~D~ of pol δ for the complex ([@bib12]). This sets an upper limit of 10 nM for the K~D~ of pol δ for PCNA encircling a P/T junction, in excellent agreement with the value (7.1 ± 1.0 nM) reported in an independent study ([@bib51]). Thus, pol δ binds much tighter to PCNA encircling a P/T junction than to P/T DNA alone ([Table 1](#tbl1){ref-type="table"}). Altogether, these studies indicate that assembly of a pol δ holoenzyme is governed by the tighter affinity of pol δ for PCNA while pol η holoenzyme assembly is dictated by the tighter affinity of pol η for P/T DNA. Thus, pol exchange during TLS may entail a competition between pol η binding to the blocked P/T junction and pol δ binding to the PCNA encircling the blocked P/T junction. To test this, we directly monitored pol exchange.

A pol δ holoenzyme was pre-assembled on a P/T DNA substrate (TT P/T, [Figure 3A](#fig3){ref-type="fig"}) and then titrated with catalytically-inactive ('dead') pol η ([Figure 3B](#fig3){ref-type="fig"}). This mutant retains all activities except DNA synthesis and will compete with pol δ for binding to a P/T junction ([@bib17]). Indeed, the fraction of pol δ holoenzymes decreased with 'dead' pol η concentration ([Figure 3C](#fig3){ref-type="fig"}), indicating that this mutant protein competes and exchanges with pol δ for binding to the P/T DNA and/or resident PCNA. From the dose-response curves ([Figure 3D](#fig3){ref-type="fig"}), *K*~i~ values of 31.7 ± 5.12 nM and 33.5 ± 5.04 nM ([Table 1](#tbl1){ref-type="table"}) are calculated for pol δ holoenzymes assembled with PCNA and (Ub)~3~-PCNA, respectively. These equivalent values exactly agree with the *K*~D~ for pol η binding to P/T DNA and the K~D~ for pol η holoenzyme formation ([Table 1](#tbl1){ref-type="table"}), suggesting that pol η binding to the P/T junction is competing with pol δ binding to PCNA encircling the P/T junction. To verify that PCNA remains on the DNA during pol exchange, we repeated these assays with Cy5-PCNA and Cy3-labeled TT P/T DNA and monitored FRET instead of DNA synthesis ([Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}). Despite the exchange of pols, the FRET signal remained constant ([Figure 3---figure supplement 2B](#fig3s2){ref-type="fig"}), indicating that PCNA does not slide off the unblocked end of the template during the competition. Altogether, these studies confirm that the exchange of pol δ for pol η at a P/T junction is independent of PCNA monoubiquitination ([@bib17]) and reveal that the binding affinity of pol η for P/T DNA drives pol exchange during TLS. Next, we probed the effect of PCNA on DNA synthesis by pols δ and η.10.7554/eLife.19788.011Figure 3.Polymerase exchange at a blocked P/T junction.(**A**) Sequence of the TT P/T DNA substrate that mimics a nascent P/T junction on the lagging strand. The size of the double-stranded DNA region agrees with the size of an initiating P/T and the requirements for assembly of a pol δ holoenzyme. The biotin tag was pre-bound to Neutravidin, preventing PCNA from sliding off the 5' end of the primer. The ssDNA is consistent with the footprint of a single RPA molecule and was pre-bound with excess RPA. The primer is labeled at the 5' terminus with ^32^P ([@bib17]). (**B**) Schematic representation of the experiment to monitor pol exchange. The experiment for pol δ alone was performed identically except for the omission of PCNA, RFC, and 'dead' pol η. (**C**) 12% denaturing sequencing gel of the primer extension products. The size of the substrate and full-length product are indicated on the right. The full-length product is only generated in the presence of a PCNA (compare lane 1 to lanes 2--10). Thus, production of the full-length product indicates the fraction of pol δ holoenzymes that withstand the influx of 'dead' pol η and, hence, the extent of pol exchange. (**D**) The fraction of pol δ holoenzyme remaining was plotted as a function of the log concentration of 'dead' pol η. The data for pol δ holoenzymes assembled with either PCNA (green) or (Ub)~3~-PCNA (blue) is shown and each point represents the average ± SD of 3 independent experiments. IC~50~ values were obtained by fitting the data to a dose-response inhibition model and *K*~i~ values ([Table 1](#tbl1){ref-type="table"}) were calculated from the IC~50~ values. *K*~i~ values of 31.7 ± 5.12 nM and 33.5 ± 5.04 nM ([Table 1](#tbl1){ref-type="table"}) were calculated for pol δ holoenzymes assembled with PCNA and (Ub)~3~-PCNA, respectively. These equivalent values exactly agree with the *K*~D~ for pol η binding to P/T DNA ([Figure 2](#fig2){ref-type="fig"}) and the K~D~ for pol η holoenzyme formation ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), suggesting that pol η binding to the P/T junction is competing with pol δ binding to PCNA encircling the P/T junction. Repeating this assay with Cy5-PCNA and Cy3-labeled TT P/T DNA and monitoring FRET instead of DNA synthesis ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}) verified that PCNA does not slide off the unblocked end of the DNA substrate template during the competition.**DOI:** [http://dx.doi.org/10.7554/eLife.19788.011](10.7554/eLife.19788.011)10.7554/eLife.19788.012Figure 3---figure supplement 1.Differential binding activities drive assembly of the pol η and pol δ holoenzymes.Assembly of a pol η holoenzyme was monitored via FRET by slight modifications to a published protocol ([@bib16]). (**A**) Schematic representation of the experiment depicted in **B** to monitor FRET under equilibrium conditions. A forked P/T DNA substrate (forked Cy3-P/T DNA) in agreement with the minimal requirements for assembly of human RFC and PCNA onto DNA was labeled with an internal Cy3 dye. This substrate also carries a 3′-biotin label. Together with the flap, the 3′-biotin label in complex with Neutravidin prevents loaded clamp from sliding off the DNA. Forked Cy3-P/T DNA (100 nM) was pre-incubated with Cy5-PCNA (100 nM), RFC (100 nM), and ATP (1 mM). Under these stoichiometric conditions, RFC loads all Cy5-PCNA onto Cy3-DNA and, in the absence of polymerase, dissociates back into solution taking all loaded PCNA with it. After the initial loading event, the clamp loading-unloading pathway reaches equilibrium where the rate constants for PCNA loading and unloading are equal and a net change in the FRET signal is no longer observed. At equilibrium, PCNA loading is highly-favored due to a much faster rate constant for PCNA loading compared to PCNA unloading ([@bib16]). During holoenzyme formation, an incoming polymerase captures loaded PCNA from DNA-bound RFC, stabilizing the sliding clamp on DNA and increasing the fraction of bound forked Cy3-P/T DNA•Cy5-PCNA. (**B**) The fractional saturation increased with free Pol η concentration and displayed a hyperbolic behavior indicative of an equilibrium binding curve. The dashed lines indicate the concentrations of Cy3-P/T DNA, Cy5-PCNA, and RFC (100 nM each, X = 100 nM) and 100% holoenzyme formation (y = 1.0). The data fit best to a one-site binding model yielding a K~D~ of 28.0 ± 5.38 nM for the forked Cy3-P/T DNA•Cy5-PCNA•Pol η complex. Such behavior is in stark contrast to that observed for pol δ in a recent report from our lab, shown in **C**. (**C**) Fractional saturation of the P/T DNA•PCNA complex as a function of the total concentration of DNA polymerase. Shown in grey is the data from **B** for pol η. Shown in red is the data for pol δ from reference ([@bib16]). In contrast to pol η, pol δ stabilized a stoichiometric amount of PCNA on DNA under the same conditions and, hence, displayed a linear increase. The line plateaued when the concentrations of total pol δ, PCNA, and RFC were equivalent (100 nM of each), and flat-lined thereafter ([@bib16]). This indicates that the total concentration of the DNA•PCNA complex (100 nM) is much greater ([\>]{.ul}10 fold) than the K~D~ of pol δ for the DNA•PCNA complex ([@bib12]). This sets an upper limit of 10 nM for the K~D~ of pol δ for PCNA loaded onto DNA, in excellent agreement with the value reported in an independent study (7.1 ± 1.0 nM) ([@bib51]).**DOI:** [http://dx.doi.org/10.7554/eLife.19788.012](10.7554/eLife.19788.012)10.7554/eLife.19788.013Figure 3---figure supplement 2.The resident PCNA remains at the blocked P/T junction during the exchange of pol δ for pol η.(**A**) Schematic representation of the experiment depicted in panel **B** to monitor the FRET between Cy5-PCNA and the Cy3-TT P/T DNA substrate. The TT P/T DNA substrate now contains a 5' Cy3 label on the primer (Cy3-TT P/T DNA, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). The pol δ holoenzyme was pre-assembled with Cy5-PCNA on the Cy3-TT P/T DNA substrate as described in [Figure 3](#fig3){ref-type="fig"} Catalytically-inactive ('dead') pol η (0--1 μM) was added and the FRET (I~670~/I~670~) was measured after a 5 min incubation (**B**) Data from experiments described in panel **A** plotted as a function of 'dead' pol η concentration. Each column represents the average ± SD of 3 independent experiments. As a control, the FRET was measured in the absence of pol δ (**red**). Under these conditions, pol δ (50 nM) stabilizes Cy5-PCNA (50 nM) on the Cy3-TT P/T DNA substrate (10 nM), maximizing the FRET signal. During the exchange of pols, if Cy5-PCNA slides off the unblocked end of the template that lacks biotin/neutravidin, the FRET signal will decrease as the concentration of 'dead' pol η is increased. However, the FRET signal remains constant up to 1 μM 'dead' pol η where essentially all of pol δ holoenzyme residing at the P/T junction has been exchanged ([Figure 3](#fig3){ref-type="fig"}). This demonstrates that PCNA does not slide off the TT P/T DNA substrate during the exchange of pol δ for pol η.**DOI:** [http://dx.doi.org/10.7554/eLife.19788.013](10.7554/eLife.19788.013)

PCNA increases the processivity of pols δ and η {#s2-3}
-----------------------------------------------

We utilized the TT P/T DNA substrate ([Figure 3A](#fig3){ref-type="fig"}) to monitor primer extension during a single DNA-binding event ([Figure 4B](#fig4){ref-type="fig"}), as previously described ([@bib17]). The first two nucleotides of the template (directly abutting the P/T junction) are both thymine (T) and primer extension is indicated by insertion of a dNTP across from the 3' T of the template. Pol η alone has substantial affinity for P/T DNA ([Table 1](#tbl1){ref-type="table"}) and will extend the primer ([Figure 4](#fig4){ref-type="fig"}, panels **C** and **D**). However, extension beyond the 3' T is severely limited such that pol η did not extend the primer more than 6 dNTPs. Thus, pol η alone is inefficient at continuous DNA synthesis. In the presence of PCNA, primer extension is stimulated 2.02 ± 0.173 fold ([Figure 4D](#fig4){ref-type="fig"}). Identical results were obtained with (Ub)~3~-PCNA, indicating that the binding of pol η to a PCNA encircling a native P/T junction is independent of PCNA monoubiquitination. Furthermore, primer extension beyond the 3' T is more prominent in the presence of a PCNA such that pol η extends the primer up to 10 dNTPs. Under the conditions of the assay, this behavior can be quantitatively analyzed at single nucleotide resolution ([@bib17]). The probability of insertion, *P~i~*, can be directly measured for each dNTP insertion step, *i*, beyond *i* = 1. For pol η alone, *P~i~*values are quite low ([Figure 5A](#fig5){ref-type="fig"}). Notably, *P~2~*is only 0.215 ± 0.0333, indicating that the population of pol η that inserts a dNTP across from the 5' T (*i* = 2) prior to dissociation is scarce. This population, *P*~2~, is referred to herein as the pol η TLS complex. In the presence of a PCNA, *P~i~* values up to *i = 6* are increased compared to pol η alone and the observed stimulations are equivalent for PCNA and (Ub)~3~-PCNA. Notably, the abundance of the pol η TLS complex is increased 2.53 ± 0.425 and 2.75 ± 0.368 fold in the presence of PCNA and (Ub)~3~-PCNA, respectively. Insertion of dNTPs beyond *i* = 6 is only observed in the presence of a PCNA and the measured *P~i~* values are equivalent in the presence of PCNA and (Ub)~3~-PCNA. Thus, binding to PCNA increases the *P~i~* for pol η independently of PCNA monoubiquitination but the effect is transient such that the extent of continuous DNA synthesis is only marginally enhanced. The latter behavior is in stark contrast to that observed for pol δ on the same substrate. Pol δ alone binds to P/T DNA with dramatically low affinity ([Table 1](#tbl1){ref-type="table"}) and will not extend the primer in the absence of PCNA ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}), in agreement with previous observations ([@bib17]). In the presence of PCNA, *P~i~* is stimulated, plateaus at \~1.0 soon after DNA synthesis initiates, and remains constant until the pol δ holoenzyme approaches the end of the DNA template ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). Thus, anchoring to PCNA dramatically enhances the *P~i~* for pol δ from 0.00 to \~1.0 and the effect is perpetual such that the extent of continuous DNA synthesis is substantially increased. Based on the *P~i~* value within the plateau, a pol δ holoenzyme that initiates DNA synthesis from a P/T junction can extend the primer up to 4600 dNTPs prior to dissociation (0.999^4600^ = 0.010), in agreement with a previous report ([@bib17]).10.7554/eLife.19788.014Figure 4.DNA synthesis by pol η.(**A**) Sequence of the T\<\>T P/T DNA substrate. This substrate is identical to the undamaged DNA substrate ([Figure 3A](#fig3){ref-type="fig"}) except the native TT sequence has been replaced with a TT-CPD (denoted **T\<\>T**, shown on right). (**B**) Schematic representation of the experiment performed to monitor primer extension by pol η under single turnover conditions. The experiment for pol η alone was performed identically except for the omission of PCNA and RFC. (**C**) 16% denaturing sequencing gel of the primer extension products for pol η alone (Lanes 1--6) and a pol η holoenzyme assembled with PCNA (lanes 7--12). The sequence of the template for each dNTP insertion step (*i*) is indicated on the right up to *i* = 10. (**D**) Quantification of the primer extension products observed in the absence of a PCNA (●), in the presence of PCNA (▪), and in the presence of (Ub)~3~-PCNA (♦). Results for undamaged (**TT P/T**) and damaged (**T\<\>T P/T**) DNA substrates are shown. The data is plotted versus time and each data point represents the average ± SD of 3 independent experiments. Data points after t = 10 s were fit to a flat line where the y-intercept reflects the amplitude. Values are reported in the inset. In contrast to that observed for pol η on the undamaged (**TT P/T**) DNA substrate, DNA synthesis by pol δ was only observed in the presence of PCNA ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}).**DOI:** [http://dx.doi.org/10.7554/eLife.19788.014](10.7554/eLife.19788.014)10.7554/eLife.19788.015Figure 4---figure supplement 1.Processive DNA synthesis by pol δ.Primer extension by pol δ was monitored under single turnover conditions on the TT P/T DNA substrate as described in [Figure 4](#fig4){ref-type="fig"} and the probability of insertion (P*~i~*) for each dNTP insertion step (*i*) was calculated. (**A**) Quantification of the primer extension products observed in the absence (●) and presence of PCNA (▪). The results are plotted versus time and each data point represents the average ± SD of 3 independent experiments. Data points after t = 10 s were fit to a flat line where the y-intercept reflects the amplitude. For comparison, the data was overlaid on the data obtained for pol η (shown in grey) on the same substrate ([Figure 4D](#fig4){ref-type="fig"}) (**C**) The probability of insertion (P*~i~*) for each step (*i*) beyond the first insertion observed in the absence (●) and presence of PCNA (▪). The results are plotted versus the insertion step and each data point represents the average ± SD of at least 3 independent experiments. For comparison, the data is overlaid on the data obtained for pol η (shown in grey) on the same substrate ([Figure 4A](#fig4){ref-type="fig"}). In contrast to pol η, DNA synthesis by pol δ is only observed in the presence of PCNA. Hence, the measured *P~i~* values only reflect dNTP insertion by pol δ holoenzymes. From *i* = 15 to *i* = 25 for pol δ, *P~i~*plateaus and remains constant in the presence of PCNA. Within this range, *P~i~*is 0.999 ± 1.96 × 10^−4^ for pol δ holoenzymes, in excellent agreement with a previous report ([@bib17]).**DOI:** [http://dx.doi.org/10.7554/eLife.19788.015](10.7554/eLife.19788.015)

The unique behaviors of pol δ and pol η holoenzymes are quite befitting of their respective cellular functions and suggest distinct mechanisms for the PCNA-dependent stimulation of processivity. Kinetically, *P~i~ = k~pol~*/(*k~pol~* + *k~off~*) where *k*~off~ and *k*~pol~ are the rate constants for dissociation of a pol into solution and dNTP insertion, respectively. Pol δ, a replicative B-family pol, inserts complementary dNTPs very fast (*k*~pol~ \~ 100 s^−1^) and maintains very high fidelity ([@bib17]; [@bib41]). However, pol δ alone has very low affinity for P/T DNA and must anchor to PCNA to efficiently replicate DNA ([@bib17]). Pol δ binds much tighter to PCNA encircling DNA (*K~D~* \<10 nM, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) than to DNA alone (\~537 nM, [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}) and effectively captures a PCNA ring encircling a nascent P/T junction to initiate DNA synthesis ([@bib16]). Thus, anchoring to PCNA dramatically decreases *k~off~* such that the *P~i~* of pol δ increases from 0.0 to \~1.0 and the extent continuous dNTP insertion increases by kilobases ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Such behavior is befitting as pol δ is responsible for replicating the lagging strand during S-phase. On the other hand, Pol η, a Y-family TLS pol, also inserts dNTPs very fast (67 s^−1^) but has a compromised fidelity, inserting incorrect dNTPs up to 10^3^-fold more frequently than pol δ does on undamaged DNA ([@bib29]; [@bib46]). Hence, DNA synthesis by pol η must be restricted to limit replication errors. Pol η has significant binding affinity for P/T DNA (29.7 nM, [Figure 2](#fig2){ref-type="fig"}) such that it can replicate DNA in the absence of PCNA, albeit with distributive behavior ([Figure 4](#fig4){ref-type="fig"}). In contrast to pol δ, pol η binds tighter to P/T DNA (29.7 nM, [Figure 2](#fig2){ref-type="fig"}) that to PCNA (111 nM, [Figure 1](#fig1){ref-type="fig"}). Thus, anchoring to PCNA marginally decreases *k~off ~*for pol η such that the *P~i~* increases only \~ 1.4--2.5-fold and the extent of continuous dNTP insertion increases by 4 nucleotides ([Figure 4](#fig4){ref-type="fig"}). This behavior may be critical for pol η's cellular role in replicating small patches of undamaged DNA during common fragile site replication and somatic hypermutation ([@bib21]; [@bib37]). In human cells, pol η is also responsible for the error-free replication of CPDs during TLS ([@bib47]). Next, we characterized the activity of pol η on a P/T DNA substrate containing a thymine-thymine CPD (TT-CPD) directly abutting the P/T junction (T\<\>T P/T, [Figure 4A](#fig4){ref-type="fig"}).

TLS across a CPD by pol η is independent of PCNA monoubiquitination {#s2-4}
-------------------------------------------------------------------

As observed for the undamaged substrate, primer extension on the T\<\>T P/T (that is damaged) substrate is prominent with pol η alone ([Figure 4D](#fig4){ref-type="fig"}) and the *P~i~*values ([Figure 5B](#fig5){ref-type="fig"}) are low such that dNTP insertion beyond *i* = 6 is not observed. *P~2~* is increased 1.65 ± 0.221 fold on the damaged substrate, confirming that pol η is inherently more efficient at replicating a TT-CPD compared to a native sequence ([@bib30]). However, the abundance of the pol η TLS complex is still limited (*P~2~* = 0.349 ± 0.00298), suggesting that DNA synthesis by pol η alone is inefficient for cellular TLS as it necessitates multiple binding encounters. Primer extension on the damaged substrate is stimulated to the same extent in the presence of PCNA and (Ub)~3~-PCNA ([Figure 4D](#fig4){ref-type="fig"}), indicating that the binding of pol η to a PCNA encircling a damaged P/T junction is independent of PCNA monoubiquitination. Furthermore, the observed stimulations are approximately the same as those observed on the undamaged DNA substrate, indicating that a TT-CPD has no effect on the loading of PCNA onto P/T DNA, formation of a pol η holoenzyme, or the ensuing insertion of a dNTP across from the 3'T. In the presence of a PCNA, *P~i~* values up to *i* = 6 ([Figure 5B](#fig5){ref-type="fig"}) for the damaged substrate are increased compared to pol η alone and the observed stimulations are equivalent for PCNA and (Ub)~3~-PCNA. Insertion of dNTPs beyond *i* = 6 is only observed in the presence of a PCNA on the damaged substrate and the measured *P~i~* values are equivalent in the presence of PCNA and (Ub)~3~-PCNA. These behaviors agree with that observed for the undamaged substrate and indicate that the ubiquitin moieties conjugated to PCNA have no effect on DNA synthesis by a pol η holoenzyme.10.7554/eLife.19788.016Figure 5.Processive DNA synthesis by pol η.Probability of insertion (P*~i~*) for each dNTP insertion step (*i*) beyond the first was calculated for the experiments depicted in [Figure 4](#fig4){ref-type="fig"}. Results obtained in the absence of PCNA (●), in the presence of PCNA (▪), and in the presence of (Ub)~3~-PCNA (♦) are plotted versus the insertion step up to *i* = 12 and each data point represents the average ± SD of at least 3 independent experiments. dNTP insertion beyond *i* = 10 was not observed for pol η. (**A --B**) Processivity of pol η on undamaged (panel **A**, **TT P/T**) and damaged (panel **B**, **T\<\>T P/T**) P/T DNA substrates. The dashed line denotes the population of pol η that inserts a dNTP across from the 5' T of a given template prior to dissociation, that is the pol η TLS complex. The arrows denote the increase in the extent of continuous DNA synthesis observed in the presence of a PCNA. (**C**) Dissociation of the pol η TLS complex. The fraction of the Pol η TLS complex (y) remaining at each insertion step, *i*, was determined for the undamaged (**TT P/T**) and damaged (**T\<\>T P/T**) P/T DNA substrates using the *P~i~* values reported in panels **A** and **B**. Results obtained in the absence of PCNA (●), in the presence of PCNA (▪), and in the presence (Ub)~3~-PCNA (♦) are plotted versus the insertion step, *i*. The divergence observed in the presence of a PCNA for the damaged and undamaged substrates is highlighted in yellow.**DOI:** [http://dx.doi.org/10.7554/eLife.19788.016](10.7554/eLife.19788.016)

Interestingly, the abundance of the pol η TLS complex (*P*~2~) in the presence of a PCNA is approximately the same for the undamaged ([Figure 5A](#fig5){ref-type="fig"}) and damaged ([Figure 5B](#fig5){ref-type="fig"}) substrates. Thus, a pol η holoenzyme replicates a TT-CPD lesion and a native TT sequence with the same efficiency. Furthermore, *P*~3~ values measured in the presence of a PCNA are approximately the same for each substrate, indicating that a pol η holoenzyme has the same probability of extending a primer one dNTP beyond the 5' T of a TT-CPD lesion as it does for the native TT sequence. Thus, binding of pol η to a PCNA encircling a P/T junction generically increases the efficiency of DNA synthesis across an adjacent di-pyrimidine sequence. However, a clear divergence in the behavior of pol η on the damaged and undamaged substrates is evident in the presence of a PCNA. *P~i~*for both substrates peaks at *i* = 4 and then decreases. On the undamaged substrate ([Figure 5A](#fig5){ref-type="fig"}), *P~4~* is higher and *P~i~* decreases such that \>12.5% of the pol η TLS complex extends the primer an additional 6 dNTPs ([Figure 5C](#fig5){ref-type="fig"}). Insertion of dNTPs is not observed beyond *i* = 10. On the damaged substrate ([Figure 5B](#fig5){ref-type="fig"}), *P~4~* is lower and the descent of *P~i~* is much more rapid such that \<2% of the pol η TLS complex extends the primer 6 dNTPs beyond the TT-CPD and dNTP insertion is not observed beyond *i* = 9 ([Figure 5C](#fig5){ref-type="fig"}). This disparity is not observed in the absence of a PCNA. Thus, a pol η holoenzyme is far less efficient at continuously extending a primer beyond a CPD lesion. In other words, replication of a CPD by a pol η holoenzyme selectively promotes dissociation of pol η downstream of the di-pyrimidine sequence. Perhaps the abnormally structured base pairs downstream of a CPD ([@bib36]) weaken the affinity of pol η for the P/T junction (that is increase *k*~off~) and/or slow down dNTP insertion (i.e., decrease *k*~pol~) ([@bib22]).

It should be noted that the *P~i~*values measured for pol η in the presence of a PCNA ([Figures 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}) account for dNTP insertions catalyzed by pol η alone and pol η holoenzymes up to and including *i* = 6. Based on the binding affinities of pol η for P/T DNA and a PCNA measured in this study ([Table 1](#tbl1){ref-type="table"}), only a fraction (\~60%) of the pol η bound to the P/T DNA is also bound to the PCNA encircling the P/T junction under the conditions of the assay described in [Figure 4](#fig4){ref-type="fig"} Thus, each dNTP insertion step [\<]{.ul} *i* = 6 is carried out by a combination of pol η alone and pol η holoenzymes and, hence, the measured *P~i~*values account for both events. However, by directly comparing the activity of pol η in the absence and presence of a PCNA on both damaged and undamaged substrates, it is clearly evident that the majority of dNTP insertions [\<]{.ul} *i* = 6 are catalyzed by pol η holoenzymes when a PCNA is present. In particular, the rapid dissociation of the pol η TLS complex in the absence of a PCNA ([Figure 5C](#fig5){ref-type="fig"}) indicates that dNTP insertion beyond *i* = 2 is predominantly catalyzed by pol η holoenzymes when a PCNA is present. Thus, *P~i~*values measured in the presence of a PCNA for *i* \<6 are likely an underestimate for pol η holoenzymes due to the contribution of pol η alone. Insertion of dNTPs by pol η beyond *i* = 6 is only observed in the presence of a PCNA and, thus, only reflects the activity of pol η holoenzymes.

Discussion {#s3}
==========

In this report, we provide extensive quantitative evidence that the binding of pol η to PCNA and DNA synthesis by a pol η holoenzyme are both independent of PCNA monoubiquitination. Thus, direct binding of pol η to the ubiquitin moieties conjugated to PCNA, if it occurs, is dispensable for pol η-mediated TLS across a UV-induced CPD lesion, in agreement with in vivo studies. This refutes the recruitment/displacement model for human TLS and, hence, indicates that pol switching occurs independently of PCNA monoubiquitination. In support of our conclusion, we compared the activities of pols δ and η in various experimental contexts. Together with previous reports from our lab, the results from these studies indicate that pol switching during TLS on the lagging strand is an efficient and passive process that occurs independently of PCNA monoubiquitination, as discussed below ([Figure 6](#fig6){ref-type="fig"}).10.7554/eLife.19788.017Figure 6.Polymerase exchange during TLS on the lagging strand.While replicating a lagging strand template, pol δ maintains a loose association with PCNA while inserting dNTPs very fast. (**1**) Upon encountering a DNA lesion (**X**) it cannot accommodate, such as UV-induced CPD, pol δ rapidly dissociates from DNA, leaving PCNA behind. Pol δ may re-bind to the resident PCNA but pol δ-mediated DNA synthesis cannot resume until the lesion is replicated by one or more TLS pols. (**2**) The binding affinity of pol η for P/T DNA drives the passive exchange of pols at a blocked P/T junction. (**3**) Once localized to the blocked P/T junction, the resident PCNA stabilizes pol η on the DNA, increasing the efficiency of the ensuing TLS. (**4**) After replicating the CPD, dissociation of pol η is promoted downstream of the damage. This provides an efficient and generic pathway for pol η to depart a damaged template and, hence, limits the extent of error-prone DNA synthesis by pol η downstream of a CPD. In the event that pol η-mediated TLS across and beyond a CPD lesion terminates with a mismatched P/T junction, another TLS pol, such as pol ζ, may access the P/T junction upon pol η's departure and faithfully extend the mismatch, allowing DNA synthesis by pol δ to resume.**DOI:** [http://dx.doi.org/10.7554/eLife.19788.017](10.7554/eLife.19788.017)

Polymerase exchange during TLS {#s3-1}
------------------------------

Pol δ, a replicative B-family pol, inserts complementary dNTPs very fast (*k*~pol~ \~ 100 s^−1^) and maintains very high fidelity ([@bib17]; [@bib41]). However, pol δ alone has very low affinity for P/T DNA and must anchor to PCNA to efficiently replicate DNA ([@bib17]). Pol δ binds much tighter to PCNA encircling DNA than to DNA alone ([Table 1](#tbl1){ref-type="table"}) and effectively captures PCNA encircling a P/T junction to initiate DNA synthesis ([@bib16]). A pol δ holoenzyme inserts dNTPs much faster (\>700 fold) than pol δ dissociates from PCNA encircling DNA ([@bib17]). Thus, anchoring to PCNA dramatically increases the *P~i~* of pol δ from 0.0 to \~1.0 such that the extent of continuous dNTP insertion (that is processivity) increases by kilobases ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Upon encountering a lesion it cannot accommodate, such as a UV-induced CPD, pol δ rapidly and passively dissociates into solution, leaving PCNA behind on the DNA ([@bib17]). Pol δ may re-bind to the PCNA residing at a blocked P/T junction but pol δ-mediated DNA synthesis cannot resume until the lesion is replicated ([Figure 6](#fig6){ref-type="fig"}, step 1). This suggests that pol η may access the blocked P/T junction in the interim that pol δ has vacated. Our previous study demonstrated that this pol exchange is independent of PCNA monoubiquitination and rate-limited by the rapid and passive dissociation of pol δ from the resident PCNA ([@bib17]). The current study revealed that pol η binds much tighter to P/T DNA than to a PCNA ([Table 1](#tbl1){ref-type="table"}) such that pol exchange is driven by the binding affinity of pol η for the P/T DNA ([Figure 3](#fig3){ref-type="fig"}). Thus, pol exchange during TLS on the lagging strand is a competition between pol η binding to a blocked P/T junction and pol δ binding to PCNA encircling a blocked P/T junction ([Figure 6](#fig6){ref-type="fig"}, step 2).

The binding affinity of pol η for PCNA is substantial and independent of PCNA monoubiquitination ([Table 1](#tbl1){ref-type="table"}). Once localized to a P/T junction, pol η binds to the resident PCNA, forming a holoenzyme. This association stabilizes pol η at a P/T junction and increases the efficiency of the ensuing DNA synthesis across a generic di-pyrimidine sequence directly abutting the P/T junction ([Figure 6](#fig6){ref-type="fig"}, step 3). However, a pol η holoenzyme is far less efficient at continuously extending a primer beyond a CPD compared to the native sequence ([Figures 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}). Thus, replication of a CPD by a pol η holoenzyme selectively promotes dissociation of pol η downstream of the di-pyrimidine sequence. This provides an efficient and generic pathway for pol η to depart a damaged template and, hence, limits the extent of error-prone DNA synthesis by pol η downstream of a CPD. This may account for the remarkably low error-rates observed in human cells for pol η-mediated TLS after UV irradiation ([@bib47]). Pol δ is inefficient at extending mismatched primers ([@bib31]). In the event that pol η-mediated TLS across and beyond a CPD lesion terminates with a mismatched P/T junction, another TLS pol, such as pol ζ, may access the P/T junction upon pol η's departure and faithfully extend the mismatch ([@bib25]), allowing DNA synthesis by pol δ to resume ([Figure 6](#fig6){ref-type="fig"}, step 4).

Role of monoubiquitinated PCNA during TLS {#s3-2}
-----------------------------------------

Monoubiquitination of PCNA is imperative for replication through CPD lesions in human cells ([@bib48]) and the signal for this PTM is the build-up and persistence of RPA-coated ssDNA downstream of blocked P/T junctions ([@bib14]). In human cells irradiated with UV at the G~1~/S border, RPA foci rapidly built up, persisted through S-phase, and then disappeared primarily in G~2~/M phase when the bulk of chromosomal replication had been completed ([@bib8]). An earlier study observed a similar trajectory for monoubiquitinated PCNA ([@bib34]), which only resides on DNA in vivo ([@bib14]). Thus, the role(s) of monoubiquitinated PCNA during TLS may be initiated at the onset of S-phase and persist into G~2~/M. Given the large size of ssDNA stretches (100's to 1000's of nucleotides) and the remarkably low error rates observed in vivo after UV exposure, this argues strongly against monoubiquitinated PCNA selectively and directly promoting error-prone DNA synthesis by TLS pols ([@bib14]; [@bib23]; [@bib48]). This study demonstrates that the binding of pol η to PCNA and the ensuing TLS across a UV-induced CPD are both independent of PCNA monoubiquitination. Furthermore, pol ζ, a B-family TLS pol implicated in TLS following UV exposure (see above), does not contain a ubiquitin-binding domain yet assembly of pol ζ into replication foci at UV-induced lesions requires monoubiquitination of PCNA by Rad6/Rad18 ([@bib25]; [@bib49]). Together, this suggests that the role(s) of PCNA monoubiquitination in human TLS across and past a UV-induced DNA lesion is indirect. A recent study from our lab demonstrated that assembly/disassembly of a pol δ holoenzyme and continuous DNA synthesis by a pol δ holoenzyme are both independent of PCNA monoubiquitination ([@bib17]). The ubiquitin moieties attached to PCNA do not alter the conformation of the sliding clamp ring ([@bib9]) nor do they shelter the region of PCNA that interacts with DNA pols ([@bib44], [@bib45]). Hence, monoubiquitination of PCNA is not envisioned to have any effect on DNA synthesis by a pol ε holoenzyme on a leading strand template. Collectively, this argues against PCNA monoubiquitination indirectly promoting TLS by destabilizing the replicative pol holoenzymes. In addition, this suggests the ubiquitin moieties attached to PCNA do not need to be removed immediately after TLS so that DNA synthesis by the replicative pols can resume. Indeed, de-ubiquitination of PCNA in human cells irradiated with UV does not occur until after the bulk of DNA synthesis (that is S-phase) has been completed ([@bib34]). We propose that the ubiquitin moieties conjugated to PCNA indirectly promote DNA synthesis in general at sites of DNA damage. One possibility is that monoubiquitinated PCNA alters the local chromatin structure encompassing a DNA lesion to promote DNA synthesis past and beyond the offending damage. In a recent study on human cells, pol η was transiently immobilized within replication foci after treatment with DRAQ5, a DNA intercalating agent that temporarily disrupts chromatin structure without eliciting PCNA monoubiquitination or a DNA damage response ([@bib38]). This suggests that transient opening of chromatin promotes access of pol η to DNA. In the same study, accumulation of pol η into replication foci following UV irradiation was independent of PCNA monoubiquitination but monoubiquitinated PCNA increased the residence time of pol η within the foci, similar to DRAQ5 treatment. Thus, it is possible that the ubiquitin moieties conjugated to PCNA facilitate the exposure of DNA at blocked P/T junctions. In humans, chromatin assembly factor 1 (CAF-1) deposits histones H3/H4 on nascent DNA immediately after passage of the replication fork, initiating nucleosome assembly. This process is mediated by a direct interaction between CAF-1 and PCNA left behind on the DNA ([@bib42]). In cell-free extracts, CAF-1 efficiently triggers a progressing wave of nucleosome assembly on a gapped DNA substrate in the absence of DNA synthesis ([@bib32]). Such activity may impede TLS in vivo by limiting the access of DNA pols to sites of DNA damage. The amino acid residues within a PCNA ring that are required for CAF-1 mediated histone deposition are far removed from the region of PCNA that interacts with replication proteins, including pols δ and η ([@bib50]). Results from computational studies suggest that the ubiquitin moieties conjugated to PCNA at lysine residue(s) K164 could selectively block the CAF-1 binding sites on PCNA ([@bib45]). This may preclude the binding of CAF-1 to PCNA encircling a blocked P/T junction, inhibiting histone deposition until the offending DNA lesion is replicated. Further studies will test this hypothesis.

Materials and methods {#s4}
=====================

Oligonucleotides {#s4-1}
----------------

Oligonucleotides were synthesized by Integrated DNA Technologies (Coralville, IA) and purified on denaturing polyacrylamide gels. Concentrations were determined from the absorbance at 260 nm using the calculated extinction coefficients. The P/T DNA substrates ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) were annealed as previously described ([@bib17]). For experiments in which DNA synthesis was measured, the primer was 5'-labeled with ^32^P as previously described ([@bib17]).

Recombinant human proteins {#s4-2}
--------------------------

Catalytically-inactive ('dead') pol η was prepared by mutating residues D115 and E116 within the catalytic core of human pol η to alanine (D115A/E116A) using forward (5'-GAACGTGCCAGC ATTGCTGCGGCTTACGTAGATCTG-3') and reverse (5'-CAGATCTACGTAAGCCGCAGCAATGCTGGCA CGTTC-3') primers to the pET21A plasmid expressing the full-length, human pol η protein. These amino acid residues are necessary for catalytic activity. In vivo, this full-length, human pol η mutant retains all biological functions except DNA synthesis activity ([@bib3]; [@bib10]; [@bib37]). Wild-type and catalytically-inactive pol η was purified from the pET21A-hPol η expression vector by slight modifications of a published protocol ([@bib24]). The protein concentration was determined from the calculated extinction coefficient (64010 M^−1^cm^−1^) and verified by Bradford assay using BSA as a protein standard. For N-terminally labeling pol η with Cy3 NHS ester (GE healthcare UK Limited, Buckinghamshire, UK), Pol η was exchanged into labeling buffer (20 mM HEPES pH 6.5, 200 mM NaCl, 10% glycerol), mixed with a five-fold excess of Cy5 NHS ester, incubated for 1 hr at 4°C, and then loaded onto a G25 size exclusion column (GE healthcare, Uppsala, Sweden) that had been pre-equilibrated with Pol η storage buffer (25 mM tris pH 7.5, 250 mM NaCl, 10% glycerol and 5 mM β-Mercaptoethanol). The column was developed with Pol η storage buffer and the labeled protein fraction was collected and concentrated. The labeling efficiency (1.6 Cy3 dyes/pol η protein on average) was calculated according to the manufacturer's protocol. The concentration of active pol η was determined by active site titration according to a published protocol ([@bib46]). Wild-type and Cy3-labeled retained more than 95 and 80% activity, respectively. All concentrations of pol η indicated throughout the text refer to the final concentration of active protein. Exonuclease-deficient pol δ was prepared by mutating D402 in the catalytic (POLD1) subunit to alanine (D402A) using forward (5'-CAACATCCAGAACTTC GCCCTTC CGTACCTCATC-3') and reverse (5'-GATGAGGTACGGAAGGGCGAAGTTCTGGATGTTG-3') primers to the plasmid expressing the wild-type POLD1 subunit ([@bib27]). This pol δ mutant was characterized previously ([@bib17]), used in all of the primer extension assays reported herein, and is referred to simply as pol δ throughout the text. Wild-type PCNA (PCNA), Cy5-labeled PCNA (Cy5-PCNA), monoubiquitinated PCNA ((Ub)~3~-PCNA), exonuclease-deficient pol δ (Pol δ), RPA, and a truncated form of RFC (RFC) were obtained as described in a previous report ([@bib17]).

All experimental procedures described below were performed at room temperature in 1X replication assay buffer (25 mM TrisOAc, pH 7.7, 10 mM Mg(OAc)~2~, 125 mM KOAc) supplemented with 0.1 mg/ml BSA, 1 mM DTT and the ionic strength was adjusted to physiological (200 mM) with KOAc.

Steady state FRET measurements {#s4-3}
------------------------------

FRET measurements were done in a Jobin Yvon fluoromax-4 fluorimeter. The fluorescence emission intensity maxima for the Cy3 donor (I~570~) and the Cy5 acceptor (I~670~) occur at 570 nm and 670 nm, respectively. In the presence of both Cy3-pol η and Cy5-PCNA, a FRET is indicated by an increase in I~670~ and a concomitant decrease in I~570~. This can be quantified by monitoring the I~670~/I~570~ ratio. For the experiments depicted in [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}, Cy5-PCNA (20 nM) and Cy3-Pol η (200 nM) were pre-incubated, excited at 514 nm, and the fluorescence emission intensity was recorded from 540 to 750 nm. For the direct titration experiments depicted in [Figure 1A](#fig1){ref-type="fig"} and 20 nM Cy3-Pol η was pre-incubated with increasing concentrations of Cy5-PCNA, excited at 514 nm, and the fluorescence emission intensity at 570 nm (Cy3 donor fluorescence emission maximum, I~570~) was measured. In order to account for the signal generated from Cy5-PCNA, each value was corrected for by the corresponding I~570~ value obtained in the absence of pol η. The donor fluorescence quenching efficiency (E~dq~) was then calculated at each Cy5-PCNA concentration by the equation E~dq~ = 1-I~DA/~I~D~, where I~DA~ and I~A~ are the I~570~ values obtained in the presence and absence of Cy5-PCNA, respectively. The data was analyzed as described below for an equilibrium binding assay. For the competitive titration experiments depicted in [Figure 1C](#fig1){ref-type="fig"}, the Cy3-Pol η•Cy5-PCNA complex (200 nM Cy3-Pol η, 20 nM Cy5-PCNA) was pre-assembled, an unlabeled PCNA was added (either PCNA or (Ub)~3~-PCNA, 0--5 μM), and then the I~670~/I~670~ ratio was measured. As a control to demonstrate that Cy3 does not affect the interaction between pol η and PCNA, these assays were repeated with pol η (0--5 μM) as the unlabeled competitor ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). The data was analyzed as described below for competitive inhibition assays. For holoenzyme assembly depicted in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}, RFC (100 nM), Cy5-PCNA (100 nM) and Cy3-P/T DNA (100 nM) were pre-incubated in the presence of 1 mM ATP. Increasing concentrations of unlabeled Pol η were then added and the I~670~/I~570~ ratio was measured. The data was analyzed as described below for equilibrium binding assays. For the FRET-based competition assays ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}), the competitive primer extension assays ([Figure 3](#fig3){ref-type="fig"}) were repeated using a TT P/T DNA substrate containing a 5' Cy3-label on the primer (Cy3-TT P/T, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) and Cy5-PCNA. Under these conditions, pol δ (50 nM) stabilizes Cy5-PCNA (50 nM) on the Cy3-TT P/T DNA substrate (10 nM), maximizing the FRET signal. After a 5 min incubation with various concentrations of 'dead' pol η (0--1 μM), the FRET signal (I~670~/I~570~) was measured. As a control, FRET was measured in the absence of pol δ and pol η.

Fluorescence anisotropy {#s4-4}
-----------------------

10 nM of the fluorescein-labeled P/T DNA substrate (FLUOR-P/T DNA, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) was titrated with various concentrations of either pol η or pol δ and the fluorescence polarization was measured.

Primer extension assays {#s4-5}
-----------------------

Single-turnover primer extension assays were carried out with pols δ or η exactly as described in a previous report ([@bib17]). Erroneous insertion of ATP during the pre-incubation period did not occur with pol δ under any experimental condition. For pol η, such events did not occur beyond *i* = 2 and were only notable (that is \>10% of the total amount of primer extension products) for the T\<\>T P/T DNA substrate in the absence of a PCNA. Controls experiments were carried out to account for such activity. The primer extension assays described in [Figure 4](#fig4){ref-type="fig"} were repeated except aliquots were quenched prior to the addition of the trap/dNTPs. For each condition, the concentration of each primer extension product observed during the pre-incubation was subtracted from the corresponding primer extension products observed over the time course of the experiment. The probability of insertion (*P~i~*) was calculated as described in a previous report ([@bib17]). The pre-assembled pol η•P/T DNA complex that replicates the first two nucleotides of a given template within a single binding encounter is *P*~2~ and is referred to as the \'Pol η TLS complex.\' The fraction of the Pol η TLS complex (y) remaining at each insertion step, *i*, was determined by normalizing *P*~2~ to 1.0 and multiplying by the *P~i~* values for each involved step. For example, the fraction of the pol η TLS complex remaining after 2 dNTP insertion is y = 1.0 × *P~3~* × P~4~.

For the competition assays, the pol δ holoenzyme was pre-assembled as in the single-turnover primer extension assays ([@bib17]) with minor differences in the final concentrations: 10 nM TT P/T DNA, 40 nM Neutravidin, 50 nM RPA, 50 nM PCNA trimer (either wild type or (Ub)~3~-PCNA), 1 mM ATP, 10 nM RFC, and 50 nM pol δ. The pol δ holoenzyme was pre-incubated for 1 min prior to the addition of catalytically-inactive ('dead') pol η (0--5 μM). After 5 min, DNA synthesis by surviving pol δ holoenzymes was initiated by addition of dNTPs (100 μM of each). After 30 s, the reactions were quenched and analyzed by denaturing PAGE. For each time point, the fraction of pol δ holoenzyme remaining was calculated by dividing the concentration of full-length product (62-mer) by the total concentration of primer extension products.

Data analysis {#s4-6}
-------------

For all equilibrium binding experiments, the raw data $(\text{y})$ was fit to a one-site binding model ([Equation 1](#equ1){ref-type="disp-formula"}) where $R$ is the range, $K_{D}$ is the equilibrium binding constant, and $C$ is a constant.$$\text{y}~ = \frac{\text{R}\left\lbrack \text{Ligand} \right\rbrack_{\text{Total}}}{K_{D} + ~\left\lbrack \text{Ligand} \right\rbrack_{\text{Total}}} + \text{C}$$

In all experiments, the initial concentration of the substrate is substantial and, hence, depletes the concentration of added ligand $(\lbrack Ligand\rbrack_{Total})$, that is $\lbrack Ligand\rbrack_{free} < \lbrack Ligand\rbrack_{Total}$. In order to obtain the most accurate value for $K_{D}$, each experiment was normalized by utilizing the values for and to calculate the fractional saturation of the substrate and $\lbrack Ligand\rbrack_{Free}$. The fractional saturation $(F)$ of the substrate was plotted versus $\lbrack Ligand\rbrack_{Free}$ and fit to a one-site binding model ([Equation 2](#equ2){ref-type="disp-formula"}) where $Y_{max}$ is the maximum specific binding and is equal to 1.0 (that is, the range).$$\text{F}~ = \frac{\text{Y}_{\text{max}}\left\lbrack \text{Ligand} \right\rbrack_{\text{Free}}}{K_{D} + ~\left\lbrack \text{Ligand} \right\rbrack_{\text{Free}}}$$

For all competitive inhibition experiments, the measured experimental signal $(\text{y})$ was plotted versus the log concentration of the respective competitor and the data was fit to a dose-response inhibition model ([Equation 3](#equ3){ref-type="disp-formula"}) where $Y_{min}$ and $Y_{max}$ are the minimum and maximum experimental signals, respectively, and $IC_{50}$ is the concentration of competitor that gives a response halfway between $Y_{max}$ and $Y_{min}$.$$y\  = \ Y_{\min}\  + \left\lbrack \frac{Y_{\max} - Y_{\min}}{1 + 10^{({{\lbrack{Competitor}\rbrack} - {LogIC}_{50}})}} \right\rbrack$$

Each data set was then normalized using the respective $Y_{min}$ and $Y_{max}$ values to plot the fraction $(F)$ of the pre-assembled complex remaining versus the log concentration of the respective competitor and fit to a dose-response inhibition model ([Equation 4](#equ4){ref-type="disp-formula"}) where $Y_{max}$ is the range and equal to 1.0.$$\text{y}~ = ~\left\lbrack \frac{\text{Y}_{\text{max}}}{1 + 10^{({{\lbrack\text{Competitor}\rbrack} - \text{LogIC}_{50}})}} \right\rbrack$$

Under the conditions of the competitive inhibition assays, the Cheng-Prusoff correction for obtaining the dissociation constant for the competitive inhibitor (that is, inhibition constant, $K_{i}$) from the experimentally measured $IC_{50}$ and values is not exact. We utilized the exact solution ([Equation 5](#equ5){ref-type="disp-formula"}) provided by Munson and Rodbard ([@bib33]; [@bib35]) where $L_{T}$ is the total concentration of the ligand that the competitive inhibitor will bind to and $\text{y}_{0}$ is the initial bound to free ratio for this ligand prior to the addition of the competitive inhibitor.$$K_{i} = \frac{\text{IC}_{50}}{1 + \frac{\text{L}_{\text{T}}\left( \text{y}_{0} + 2 \right)}{2K_{\text{D}}\left( \text{y}_{0} + 1 \right)} + \text{y}_{0}} - K_{D}(\frac{\text{y}_{0}}{\text{y}_{0} + 2})$$

In [Figure 1C](#fig1){ref-type="fig"}, $L_{T}$ and $\text{y}_{0}$ refer to Cy3-pol η and $\text{y}_{0}$ is calculated from the measured $K_{D}$ for the Cy3-pol η•Cy5-PCNA complex ([Figure 1B](#fig1){ref-type="fig"}). In [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}, $L_{T}$ and $\text{y}_{0}$ refer to Cy5-PCNA and $\text{y}_{0}$ is calculated from the measured $K_{D}$ for the Cy3-pol η•Cy5-PCNA complex ([Figure 1B](#fig1){ref-type="fig"}). In [Figure 3](#fig3){ref-type="fig"}, $L_{T}$ and $\text{y}_{0}$ refer to the TT P/T DNA•PCNA complex and $\text{y}_{0}$ is calculated from the $K_{D}$ reported for the pol δ•PCNA•P/T DNA complex ([@bib51]).
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Thank you for submitting your article \"Characterization of human translesion DNA synthesis across a UV-induced DNA lesion\" for consideration by *eLife*. Your article has been favorably evaluated by John Kuriyan as the Senior Editor and three reviewers, one of whom, Michael R Botchan (Reviewer \#1), is a member of our Board of Reviewing Editors.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This paper describes mostly equilibrium experiments to address the question whether PCNA ubiquitylation has a direct role in TLS at lesions by promoting recruitment or activity of the TLS polymerase η. The very beautiful biochemistry reported here makes it clear that the Ub modification of PCNA can\'t play a key role in recruitment for either polymerase η or δ given what we know about the pathway.

The experiments show clearly that:

1\) The affinity of pol η for PCNA in solution in the absence of DNA or other factors is independent of the state of ubiquitination of PCNA.

2\) The affinity of pol η for a primer terminus in the absence of other factors is high (4X affinity for free PCNA).

3\) In an exchange experiment pol η can equilibrate with a primer terminus preloaded with PCNA-pol δ during five-minute incubation. PCNA remains associated with the DNA during the exchange of η for δ.

4\) PCNA increases the processivity of pol η somewhat, but in the presence of PCNA, RF-C, and RPA, synthesis across a CPD by pol η is largely independent of the ubiquitination status of PCNA. Copying a CPD is associated with a higher rate of dissociation downstream.

Essential revisions:

1\) The Discussion (and probably the Introduction) should be rewritten to focus on issues that are directly addressed by the experiments presented. In particular, much of the Discussion is devoted to analyzing two models for the timing of TLS -- the \"on-the-fly\" model in which an exchange to a TLS pol occurs at the fork and the post-replicative gap model in which TLS occurs in gaps left behind after replication restarts beyond the lesion. Distinguishing between these two models requires kinetic arguments and the authors make such arguments based on data in other papers. But this paper has no kinetics in it and really doesn\'t contribute much to the distinction between the models, much less to the grand synthesis model presented. The observation that the binding and activity of pol η are not affected by the state of ubiquitination of PCNA could be easily accommodated by either model. It would be appropriate in our view to stick to the main conclusions that can be drawn from the data and their implications -- these relate to the question of whether PCNA ubiquitination plays a direct role in TLS. The authors state their conclusion at the beginning of the discussion, but then spend most of the time speculating about issues that are not germane to the experiments. A concise speculation about what role Ub-PCNA plays in the TLS pathway is relevant since the genetics show that this is required at some step.

The study focuses on Pol η and Pol δ. It might be informative for the authors to comment briefly in the Discussion on whether/or how the work might relate to a possible function of Ubi-PCNA for synthesis by other TLS Pols and also the leading strand polymerase -- or should we take home that Ubi-PCNA has zero role on either strand?

2\) Experimentally the issue we would like to have addressed with a figure is that the authors add to the paper something they have likely done and possibly shown as a figure in their earlier work. Considering that various results compare PCNA and Ubi-PCNA and are negative (i.e. no difference between wtPCNA and Ubi-PCNA), there will be many readers that would appreciate seeing an SDS PAGE of the wtPCNA and the Ubi-PCNA, proving the PCNA is fully ubiquinated.
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Author response

*\[...\] Essential revisions:*

*1) The Discussion (and probably the Introduction) should be rewritten to focus on issues that are directly addressed by the experiments presented. In particular, much of the Discussion is devoted to analyzing two models for the timing of TLS -- the \"on-the-fly\" model in which an exchange to a TLS pol occurs at the fork and the post-replicative gap model in which TLS occurs in gaps left behind after replication restarts beyond the lesion. Distinguishing between these two models requires kinetic arguments and the authors make such arguments based on data in other papers. But this paper has no kinetics in it and really doesn\'t contribute much to the distinction between the models, much less to the grand synthesis model presented. The observation that the binding and activity of pol η are not affected by the state of ubiquitination of PCNA could be easily accommodated by either model. It would be appropriate in our view to stick to the main conclusions that can be drawn from the data and their implications -- these relate to the question of whether PCNA ubiquitination plays a direct role in TLS. The authors state their conclusion at the beginning of the discussion, but then spend most of the time speculating about issues that are not germane to the experiments. A concise speculation about what role Ub-PCNA plays in the TLS pathway is relevant since the genetics show that this is required at some step.*

*The study focuses on Pol η and Pol δ. It might be informative for the authors to comment briefly in the Discussion on whether/or how the work might relate to a possible function of Ubi-PCNA for synthesis by other TLS Pols and also the leading strand polymerase -- or should we take home that Ubi-PCNA has zero role on either strand?*

The Abstract, Introduction, and Discussion have been re-written to focus on the issue that is directly addressed by the experiments presented; polymerase switching during human TLS and the role of PCNA monoubiquitination in this process. Specifically;

The Introduction has been revised to focus on the issue to be addressed; the role of monoubiquitinated PCNA in polymerase switching during human TLS.

The Discussion has been revised to focus on the main conclusions that can be drawn from the data and their implications; polymerase exchange during human TLS is independent of PCNA monoubiquitination and PCNA monoubiquitination has an indirect role in TLS.

All discussion on the two models for the timing of TLS and the distinction between them has been removed (from the Abstract, main text, and figure legends) and a concise speculation about the indirect role of monoubiquitinated PCNA in human TLS has been provided. Accordingly, [Figure 6](#fig6){ref-type="fig"} has been revised to focus only polymerase switching during human TLS on the lagging strand.

Also, we have commented briefly in the Discussion about the function of monoubiquitinated PCNA for DNA synthesis by other TLS and the leading strand polymerase, pol ε, in response to UV radiation.

*2) Experimentally the issue we would like to have addressed with a figure is that the authors add to the paper something they have likely done and possibly shown as a figure in their earlier work. Considering that various results compare PCNA and Ubi-PCNA and are negative (i.e. no difference between wtPCNA and Ubi-PCNA), there will be many readers that would appreciate seeing an SDS PAGE of the wtPCNA and the Ubi-PCNA, proving the PCNA is fully ubiquinated.*

An SDS PAGE with wild-type PCNA and monoubiquitinated PCNA has been provided as a figure ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). This is indicated within the main text and the figure legend for [Figure 1](#fig1){ref-type="fig"}.

[^1]: These authors contributed equally to this work.

[^2]: **^\*^**[Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}, and [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"} are abbreviated as 2FS2, 3FS1, and 1FS3, respectively.
